Inhibition of Neurotensin Receptor 1 Selectively Sensitizes Prostate Cancer to Ionizing Radiation
VALERIE, Nicholas C. K, CASAREZ, Eli V, DASILVA, John O, DUNLAP-BROWN, Marya E, PARSONS, Sarah J, AMORINO, George P, DZIEGIELEWSKI, Jaroslaw
Published in Cancer research (Chicago, Ill.) (01.11.2011)
Published in Cancer research (Chicago, Ill.) (01.11.2011)
Get full text
Journal Article
A Bispecific METxMET Antibody-Drug Conjugate with Cleavable Linker Is Processed in Recycling and Late Endosomes
Perez Bay, Andres E, Faulkner, Devon, DaSilva, John O, Young, Tara M, Yang, Katie, Giurleo, Jason T, Ma, Dangshe, Delfino, Frank J, Olson, William C, Thurston, Gavin, Daly, Christopher, Andreev, Julian
Published in Molecular cancer therapeutics (02.03.2023)
Published in Molecular cancer therapeutics (02.03.2023)
Get full text
Journal Article
A Biparatopic Antibody That Modulates MET Trafficking Exhibits Enhanced Efficacy Compared with Parental Antibodies in MET-Driven Tumor Models
DaSilva, John O, Yang, Katie, Perez Bay, Andres E, Andreev, Julian, Ngoi, Peter, Pyles, Erica, Franklin, Matthew C, Dudgeon, Drew, Rafique, Ashique, Dore, Anthony, Delfino, Frank J, Potocky, Terra B, Babb, Robert, Chen, Gang, MacDonald, Douglas, Olson, William C, Thurston, Gavin, Daly, Christopher
Published in Clinical cancer research (15.03.2020)
Published in Clinical cancer research (15.03.2020)
Get full text
Journal Article
A Biparatopic Antibody-Drug Conjugate to Treat MET-Expressing Cancers, Including Those that Are Unresponsive to MET Pathway Blockade
DaSilva, John O, Yang, Katie, Surriga, Oliver, Nittoli, Thomas, Kunz, Arthur, Franklin, Matthew C, Delfino, Frank J, Mao, Shu, Zhao, Feng, Giurleo, Jason T, Kelly, Marcus P, Makonnen, Sosina, Hickey, Carlos, Krueger, Pamela, Foster, Randi, Chen, Zhaoyuan, Retter, Marc W, Slim, Rabih, Young, Tara M, Olson, William C, Thurston, Gavin, Daly, Christopher
Published in Molecular cancer therapeutics (01.10.2021)
Published in Molecular cancer therapeutics (01.10.2021)
Get full text
Journal Article
Abstract 2505: Neurotensin receptor antagonist, SR48692, sensitizes prostate cancer cells to radiation in vitro and in vivo
Casarez, Eli V., DaSilva, John O., Valerie, Nicholas C.K., Anaganti, Suresh, Dunlap-Brown, Marya E., Amorino, George P., Larner, James M., Parsons, Sarah J., Dziegielewski, Jaroslaw
Published in Cancer research (Chicago, Ill.) (15.04.2011)
Published in Cancer research (Chicago, Ill.) (15.04.2011)
Get full text
Journal Article